METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
Disease control Not yet recruitingThis study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few resistant spots in metastatic lung cancer patients who are already on targeted therapy (TKI). About 60 adults with EGFR or ALK mutations will receive radiation to those spots, and do…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug XTX501 takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new drug called XTX501 in people with metastatic non-small cell lung cancer (NSCLC) or other advanced solid tumors. The goal is to see if the drug is safe and can shrink tumors. Participants receive XTX501 alone, and researchers monitor side effects and how wel…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, olomorasib and pembrolizumab, as a first treatment for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and a PD-L1 score between 1% and 49%. The main goal is to see how long patients live without t…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC